SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.20
Spread: 1.20 (1.558%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Total Voting Rights

28 Sep 2012 16:28

RNS Number : 5070N
Accsys Technologies PLC
28 September 2012
 



AIM: AXS

NYSE Euronext Amsterdam: AXS

28 September 2012

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Total Voting Rights

 

Further to the recent announcement of the issue of ordinary shares in the Company pursuant to the Company's Employee Share Participation Plan, and pursuant to 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market of the following:

 

The issued share capital of the Company now consists of 409,141,923 ordinary shares of €0.01 each with voting rights. No ordinary shares are held in treasury.

 

The above figure of 409,141,923 ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules. This figure replaces and supersedes any figure previously announced.

 

ENDS

For further information, please contact:

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, CFO

 via Citigate Dewe Rogerson

 

Numis Securities

Nominated Adviser: Oliver Cardigan

Corporate Broking: Christopher Wilkinson

Ben Stoop

 

+44 (0)20 7260 1000

 

 

Citigate Dewe Rogerson

Ginny Pulbrook

Malcolm Robertson

Suzanne Bakker

 

+44 20 7282 2945

+44 20 7282 2867

+31 20 575 4023

 

 

Notes to Editors:

Accsys Technologies PLC(www.accsysplc.com ) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in Windsor, United Kingdom, and an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc). All group subsidiaries are ultimately 100% owned by Accsys and trade as Accsys Technologies. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) Accoya® wood production; (ii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

Accoya® wood (www.accoya.com ) is produced using Accsys' proprietary patented process, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and temperate hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. For marine uses where weight is also important, Accoya® wood for the first time provides boat builders with a wood that is strong, lightweight, durable and retains its natural beauty for far longer. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Tricoya® Wood Elements (www.tricoya.com ) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles and are used in the fabrication of wood based composites, including panel products. These composites demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

For an archive of news, visit www.accoya.com/news or www.accsysplc.com/news

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRPGUCPBUPPGAR
Date   Source Headline
27th Jun 201412:00 pmRNSNotice of Results
2nd Jun 20147:00 amRNSMasisa Option Agreement Extended
7th May 20147:00 amRNSTrading Update
29th Apr 20147:05 amRNSNotice of Trading Update
29th Apr 20147:00 amRNSGordon Campbell CBE - Chairman
12th Feb 20147:47 amRNSReplacement: Interim Management Statement
12th Feb 20147:00 amRNSInterim Management Statement
31st Jan 201410:54 amRNSTotal Voting Rights
14th Jan 201411:01 amRNSAccsys Employee Share Participation Plan
10th Jan 20149:12 amRNSNotifiable Interest
23rd Dec 20137:00 amRNSACCOYA® LICENCE AGREEMENT WITH SOLVAY FORMALLY APP
25th Nov 20137:00 amRNSInterim Results
21st Nov 20133:01 pmRNSInterim results release date and webcast
20th Sep 20134:00 pmRNSLong Term Incentive Plan
19th Sep 20134:02 pmRNSAnnual General Meeting
19th Sep 20137:00 amRNSAGM Statement
30th Aug 20133:00 pmRNSTotal Voting Rights
28th Aug 20133:01 pmRNSNotice of AGM
16th Aug 20137:00 amRNSTermination of Diamond Wood licence agreement
1st Aug 20131:37 pmRNSAnnual Report and Financial Statements
1st Aug 20131:30 pmRNSTotal Voting Rights
30th Jul 20137:03 amRNSInterim Management Statement
23rd Jul 20133:59 pmRNSDirector/PDMR Shareholding
11th Jul 20137:00 amRNSAccsys JV signs Tricoya Licence Agreement
9th Jul 20131:25 pmRNSDirectors' Interests
28th Jun 20132:03 pmRNSNotifiable Interest
25th Jun 20137:00 amRNSAnnual Financial Report
21st Jun 20137:00 amRNSAnnual results release date and webcast
6th Jun 201310:17 amRNSAccsys joins the Social Stock Exchange
2nd May 20137:08 amRNSTrading update
14th Mar 20132:05 pmRNSDirector Information
20th Feb 201311:59 amRNSDirector's Interest
14th Feb 20137:04 amRNSInterim Management Statement
5th Feb 20134:40 pmRNSSecond Price Monitoring Extn
5th Feb 20134:35 pmRNSPrice Monitoring Extension
31st Jan 20139:02 amRNSTotal Voting Rights
25th Jan 20139:03 amRNSAnnual Information Update
16th Jan 20139:00 amRNSAccsys Employee Share Participation Plan
21st Nov 20128:13 amRNSInterim Results
16th Nov 20122:00 pmRNSInterim results release date and webcast
31st Oct 20124:16 pmRNSTotal Voting Rights
23rd Oct 201210:22 amRNSNotifiable Interest
23rd Oct 20129:17 amRNSPrestigous Awards and Certification
19th Oct 20127:07 amRNSAccsys-INEOS Tricoya(R) Joint Venture
8th Oct 20127:02 amRNSAccsys Completes Joint Venture With INEOS
1st Oct 20127:01 amRNSBoard Changes
28th Sep 20124:28 pmRNSTotal Voting Rights
14th Sep 20127:02 amRNSResult of AGM
31st Aug 20124:30 pmRNSTotal Voting Rights
29th Aug 20127:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.